[PDF][PDF] TP53 Mutation and Survival in Chronic Lymphocytic Leukemia
T Zenz, B Eichhorst, R Busch, T Denzel, S Häbe… - Journal of Clinical …, 2010 - Citeseer
T Zenz, B Eichhorst, R Busch, T Denzel, S Häbe, D Winkler, A Bühler, J Edelmann…
Journal of Clinical Oncology, 2010•CiteseerTP53 Mutation and Survival in Chronic Lymphocytic Leukemia Page 1 TP53 Mutation and
Survival in Chronic Lymphocytic Leukemia Thorsten Zenz, Barbara Eichhorst, Raymonde Busch,
Tina Denzel, Sonja Häbe, Dirk Winkler, Andreas Bühler, Jennifer Edelmann, Manuela Bergmann,
Georg Hopfinger, Manfred Hensel, Michael Hallek, Hartmut Döhner, and Stephan Stilgenbauer
See accompaning articles on pages 4480, 4485, 4492, 4500 From the University of Ulm, Ulm;
University of Cologne, Cologne; Techni- cal University of Munich; LudwigMaximilians-University …
Survival in Chronic Lymphocytic Leukemia Thorsten Zenz, Barbara Eichhorst, Raymonde Busch,
Tina Denzel, Sonja Häbe, Dirk Winkler, Andreas Bühler, Jennifer Edelmann, Manuela Bergmann,
Georg Hopfinger, Manfred Hensel, Michael Hallek, Hartmut Döhner, and Stephan Stilgenbauer
See accompaning articles on pages 4480, 4485, 4492, 4500 From the University of Ulm, Ulm;
University of Cologne, Cologne; Techni- cal University of Munich; LudwigMaximilians-University …
Purpose
The precise prognostic impact of TP53 mutation and its incorporation into treatment algorithms in chronic lymphocytic leukemia (CLL) is unclear. We set out to define the impact of TP53 mutations in CLL.
Citeseer